Pro Detailing Shares Hit by Court Decision
Merrill downgraded Professional Detailing (PDII ). On Monday, a court vacated a preliminary injunction against Ranbaxy Pharmaceutical; Ranbaxy could market a generic version of Ceftin, an antibiotic Pro Detailing markets for GlaxoSmithKline. That company's action against Ranbaxy remains pending.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.